AbbVie Inc.

Key Statistics

Recent News

• AbbVie (ABBV) Stock Weighs DCF Upside Against Elevated P/E At US$227.73 Simply Wall St.

  If you are wondering whether AbbVie at around US$227.73 is still offering fair value, the starting point is to understand what the current price actually reflects. The stock has inched up 0.2% over th

• 3 Ridiculously Cheap Healthcare Stocks to Buy in June 24/7 Wall St.

  Healthcare has spent 2026 on the sidelines while the rest of the market does the heavy lifting. The Health Care Select Sector SPDR Fund (NYSEARCA:XLV) is down around 1% year to date even after a 6% on

• Why a Dividend Portfolio That Pays Your Rent May Beat Homeownership by $500,000 Over 20 Years 24/7 Wall St.

  Paying $2,000 a month in rent is often described as throwing money away. Homeownership, by contrast, is treated as the only reliable path to wealth. Yet under the right conditions, a dividend portfoli

• AbbVie (ABBV) Rises Higher Than Market: Key Facts Zacks

  AbbVie (ABBV) closed at $227.73 in the latest trading session, marking a +1.32% move from the prior day.

• What Could Push JNJ Stock Higher From Here? Trefis

  While the market fixates on the STELARA patent cliff, the rest of the business is quietly accelerating. Excluding the legacy drug, Johnson & Johnson (JNJ) grew in double digits for the quarter. The In

• JNJ Raised the Bar: So Why Is the Stock Standing Still? Trefis

  Management raised the bar two months ago, but the stock just shrugged. Here’s why the market is waiting for proof, not promises.

• 3 Stocks Estimated To Be Up To 47.8% Below Intrinsic Value Simply Wall St.

  Over the last 7 days, the United States market has dropped 2.4%, yet it remains up by 22% over the past year, with earnings forecasted to grow by 18% annually. In this context, identifying undervalued

• The Catch Hiding In Eli Lilly Stock's Growth Story Trefis

  Eli Lilly's obesity drug franchise is a juggernaut, but a surprisingly large share of its success relies on price-sensitive consumers.